VOVERAN DT (Voltarol) 50mg – 100 tablet

$7.90

Each Voveran contains 50 mg Diclofenac 100 tablet. Used to ease pain, treat arthritis, painful period (menstrual ) cycles, and treat migraine headaches.

ATC Classification: M01AB05
Active Ingrediant: Diclofenac
Generic Name: VOVERAN DT
Manufacturer: Novartis India
Strength: 50mg
Dosage Type: Tablet DT
Packaging Type: Foil in Pharmacy Box
Contains: 100 Tab

Description

What is this drug used for?

• It is used to ease pain.

• It is used to treat some types of arthritis.

• It is used to ease painful period (menstrual) cycles.

• It is used to treat migraine headaches.

• It may be given to you for other reasons. Talk with the doctor.

Frequently reported side effects of this drug

• Nausea

• Constipation

• Heartburn

• Abdominal pain

• Vomiting

• Diarrhea

• Passing gas

• Fatigue

• Common cold symptoms

• Injection site pain

• Sweating a lot

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Severe cerebrovascular disease like change in strength on one side is greater than the other, difficulty speaking or thinking, change in balance, or vision changes.

• Abdominal ulcers like severe abdominal or back pain; black, tarry, or bloody stools; vomiting blood or vomit that looks like coffee grounds; or weight gain or abnormal swelling.

• High potassium like abnormal heartbeat, confusion, dizziness, passing out, weakness, shortness of breath, or numbness or tingling feeling.

• Bleeding like vomiting blood or vomit that looks like coffee grounds; coughing up blood; blood in the urine; black, red, or tarry stools; bleeding from the gums; abnormal vaginal bleeding; bruises without a reason or that get bigger; or any severe or persistent bleeding.

• Kidney problems like unable to pass urine, blood in the urine, change in amount of urine passed, or weight gain.

• Shortness of breath

• Severe dizziness

• Passing out

• Excessive weight gain

• Swelling of arm or leg

• Chest pain

• Fast heartbeat

• Severe headache

• Vision changes

• Severe loss of strength and energy

• Painful urination

• Blood in the urine

• Liver problems like dark urine, fatigue, lack of appetite, nausea, abdominal pain, light-colored stools, vomiting, or yellow skin.

• Stevens-Johnson syndrome/toxic epidermal necrolysis like red, swollen, blistered, or peeling skin (with or without fever); red or irritated eyes; or sores in mouth, throat, nose, or eyes.

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Note: This is not a comprehensive list of all side effects. Talk to your doctor if you have questions.

 

Medication Safety Issues

Sound-alike/look-alike issues:

Diclofenac may be confused with Diflucan

Cataflam may be confused with Catapres

Voltaren may be confused with traMADol, Ultram, Verelan

 

Product Availability

Dyloject (diclofenac injection) has been discontinued in the US for more than 1 year.

 

Storage and Stability

Capsule, tablet: Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Protect from moisture.

Injection: Store at 20°C to 25°C (68°F to 77°F). Do not freeze. Protect from light.

Powder for oral solution: Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

Suppository [Canadian product]: Store at 15°C to 30°C (59°F to 86°F); protect from heat.

 

Adverse Reactions

Injection:

Cardiovascular: Cerebrovascular accident, edema, hypertension, myocardial infarction, significant cardiovascular event

Central nervous system: Dizziness, headache

Dermatologic: Exfoliative dermatitis, pruritus, skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis

Endocrine & metabolic: Fluid retention

Gastrointestinal: Abdominal pain, constipation, diarrhea, dyspepsia, esophageal perforation, flatulence, gastrointestinal ulcer (including gastric/duodenal), heartburn, intestinal perforation, nausea, vomiting

Hematologic & oncologic: Anemia, hemorrhage, prolonged bleeding time

Hepatic: Increased liver enzymes, increased serum ALT, increased serum AST, increased serum transaminases

Hypersensitivity: Anaphylactoid reaction

Local: Extravasation, infusion site reaction

Otic: Tinnitus

Renal: Renal insufficiency

Miscellaneous: Gastrointestinal inflammation, wound healing impairment

Rare but important or life-threatening: Abnormal Dreams, agranulocytosis, alopecia, anaphylaxis, angioedema, anxiety, aplastic anemia, asthma, auditory impairment, blurred vision, cardiac arrhythmia, cardiac failure, change in appetite, colitis, coma, confusion, conjunctivitis, convulsions, cystitis, depression, diaphoresis, drowsiness, dyspnea, dysuria, ecchymoses, eosinophilia, eructation, erythema multiforme, esophagitis, exfoliative dermatitis, fever, fulminant hepatitis, gastritis, gastrointestinal hemorrhage, glossitis, hallucination, hematemesis, hematuria, hemolytic anemia, hepatic failure, hepatic necrosis, hepatitis, hepatotoxicity, hyperglycemia, hypertension, hypotension, infection, insomnia, interstitial nephritis, jaundice, leukopenia, lymphadenopathy, malaise, melena, meningitis, nervousness, oliguria, palpitations, pancreatitis, pancytopenia, paresthesia, pneumonia, polyuria, proteinuria, purpura, rectal hemorrhage, renal failure, respiratory depression, sepsis, skin photosensitivity, stomatitis, syncope, tachycardia, thrombocytopenia, toxic epidermal necrolysis, tremor, urticaria, vasculitis, vertigo, weakness, weight changes

Brand

Novartis

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Shipping From

Reviews

There are no reviews yet.

Be the first to review “VOVERAN DT (Voltarol) 50mg – 100 tablet”

Your email address will not be published.